NIH Clinical Trial of Hydroxychloroquine, a Potential Therapy for Covid-19 Begins
April 11, 2020
April 11, 2020
WASHINGTON, April 11 -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has begun, with the first participants now enrolled in Tennessee.
The Outcomes Related to COVID-19 treated with hydroxychloroquine among In-patients with symptomatic Disease . . .
A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has begun, with the first participants now enrolled in Tennessee.
The Outcomes Related to COVID-19 treated with hydroxychloroquine among In-patients with symptomatic Disease . . .